参考文献/References:
[1]GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet,2024,403(10440):2100-2132.
[2]Larsen AI,L?land KH,Hovland S,et al. Guideline-recommended time less than 90?minutes from ECG to primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction is associated with major survival benefits,especially in octogenarians:a contemporary report in 11?226 patients from NORIC[J]. J Am Heart Assoc,2022,11(17):e024849.
[3]Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective[J]. Nat Rev Cardiol,2020,17(12):773-789.
[4]Heusch G. Myocardial ischemia/reperfusion:translational pathophysiology of ischemic heart disease[J]. Med,2024,5(1):10-31.
[5]Zhou M,Yu Y,Luo X,et al. Myocardial ischemia-reperfusion injury:therapeutics from a mitochondria-centric perspective[J]. Cardiology,2021,146(6):781-792.
[6]Schwartz LM. Autophagic cell death during development—Ancient and mysterious[J]. Front Cell Dev Biol,2021,9:656370.
[7]Bai L,Wu Q,Zhang X,et al. Autosis as a selective type of cell death[J]. Front Cell Dev Bio,2023,11:1164681.
[8]Fernández ?F,Liu Y,Ginet V,et al. Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation,exercise,and ischemia[J]. JCI Insight,2020;5(1):e133282.
[9]Nah J,Zhai P,Huang CY,et al. Upregulation of Rubicon promotes autosis during myocardial ischemia/reperfusion injury[J]. J Clin Invest,2020,130(6):2978-2991.
[10]Miller DR,Cramer SD,Thorburn A. The interplay of autophagy and non-apoptotic cell death pathways[J]. Int Rev Cell Mol Biol,2020,352:159-187.
[11]Cui L,Zhao LP,Ye JY,et al. The lysosomal membrane protein lamp2 alleviates lysosomal cell death by promoting autophagic flux in ischemic cardiomyocytes[J]. Front Cell Dev Biol,2020,8:31.
[12]Chen L,Mao LS,Xue JY,et al. Myocardial ischemia-reperfusion injury:the balance mechanism between mitophagy and NLRP3 inflammasome[J]. Life Sci,2024,355:122998.
[13]Yu W,Sun S,Xu H,et al. TBC1D15/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury[J]. Theranostics,2020,10(24):11244-11263.
[14]Cao Z,Tian K,Ran Y,et al. Beclin-1:a therapeutic target at the intersection of autophagy,immunotherapy,and cancer treatment[J]. Front Immunol,2024,15:1506426.
[15]Prerna K,Dubey VK. Beclin1-mediated interplay between autophagy and apoptosis:new understanding[J]. Int J Biol Macromol,2022,204:258-273.
[16]Xiang H,Zhang J,Lin C,et al. Targeting autophagy-related protein kinases for potential therapeutic purpose[J]. Acta Pharm Sin B,2020,10(4):569-581.
[17]Nah J,Sung EA,Zhai P,et al. Tfeb-mediated transcriptional regulation of autophagy induces autosis during Ischemia/Reperfusion in the heart[J]. Cells,2022,11(2):258.
[18]Kaur S,Changotra H. T he beclin 1 interactome:modification and roles in the pathology of autophagy-related disorders[J]. Biochimie,2020,175:34-49.
[19]Yamamoto H,Zhang S,Mizushima N. Autophagy genes in biology and disease[J]. Nat Rev Genet,2023,24(6):382-400.
[20]Ding Y,Wang F,Guo Y,et.al. Integrated analysis and validation of autophagy-related genes and immune infiltration in acute myocardial infarction[J]. Comput Math Methods Med,2022,2022:3851551.
[21]Li L,Cheng H,Zhou Y,et al. METTL3 regulates autophagy of hypoxia-induced cardiomyocytes by targeting ATG7[J]. Cell Death Discov,2025,11(1):37.
[22]Grazide MH,Ruidavets JB,Martinet W,et al. Association of circulating autophagy proteins ATG5 and Beclin 1 with acute myocardial infarction in a case-control study[J]. Cardiology,2024,149(3):217-224.
[23]Ren Y,Anderson AT,Meyer G,et.al. Digoxin and its Na+/K+-ATPase-targeted actions on cardiovascular diseases and cancer[J]. Bioorg Med Chem,2024,114:117939.
[24]Nah J,Zablocki D,Sadoshima J. Autosis:a new target to prevent cell death[J]. JACC Basic Transl Sci,2020,5(8):857-869.
[25]Nah J,Zablocki D,Sadoshima J. The role of autophagic cell death in cardiac disease[J]. J Mol Cell Cardiol,2022,173:16-24.
[26]Naeli P,Winter T,Hackett AP,et al. The intricate balance between microRNA-induced mRNA decay and translational repression[J]. FEBS J,2023,290(10):2508-2524.
[27]Thum T,Condorelli G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology[J]. Circ Res,2015,116(4):751-762.
[28]Li X,Luo S,Zhang J,et al. lncRNA H19 alleviated myocardial I/RI via suppressing miR-877-3p/Bcl-2-mediated mitochondrial apoptosis[J]. Mol Ther Nucleic Acids,2019,17:297-309.
[29]Deng X,Ye F,Zeng L,et al. Dexmedetomidine mitigates myocardial ischemia/reperfusion-induced mitochondrial apoptosis through targeting lncRNA HCP5[J]. Am J Chin Med,2022,50(6):1529-1551.
[30]Jung SE,Kim SW,Jeong S,et al. MicroRNA-26a/b-5p promotes myocardial infarction-induced cell death by downregulating cytochrome c oxidase 5a[J]. Exp Mol Med,2021,53(9):1332-1343.
[31]Yan K,An T,Zhai M,et al. Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2[J]. Cell Death Dis,2019,10(7):500.
[32]Hou SM,Hsia CW,Tsai CL,et al. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin:regulation by integrin αⅡbβ3 inside-out but not outside-in signals[J]. J Biomed Sci,2020,27(1):60.
[33]Zi-Chang N,Ran A,Hui-Hui S,et al. Columbianadin ameliorates myocardial injury by inhibiting autophagy through the PI3K/Akt/mTOR signaling pathway in ami mice and hypoxic H9c2 cells[J]. Phytother Res,2025,39(1):521-535.
[34]Liu Z,Ma X,Ilyas I,et al. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis:from pharmacology to pre-clinical and clinical therapeutics[J]. Theranostics,2021,11(9):4502-4515.
[35]Jiang K,Xu Y,Wang D,et al. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis[J]. Protein Cell,2022,13(5):336-359.
[36]Deng R,Jiang K,Chen F,et al. Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia[J]. Biomed Pharmacother,2022,154:113606.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(10):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(10):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(10):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(10):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(10):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(10):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(10):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[11]王娟琳 黄颖.急性心肌梗死后心脏破裂机制的研究进展[J].心血管病学进展,2022,(7):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
WANG Juanlin,HUANG Ying.Mechanism of Cardiac Rupture After Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(10):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[12]韩月清 吴建军 邹昕宇 张有奇 邢磊 杨帆.红细胞在急性心肌梗死相关冠状动脉微血管障碍中的研究进展[J].心血管病学进展,2023,(6):537.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.013]
HAN Yueqing,WU Jianjun,ZOU Xinyu,et al.Study of Red Blood Cells in Coronary Microvascular Dysfunction Associated with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2023,(10):537.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.013]